Protocol Ledger

NCT05382208 · Phase II · ACTIVE NOT RECRUITING

Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

Interventional Phase II clinical trial protocol NCT05382208 sponsored by Weill Medical College of Cornell University in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-08-22 Enrollment: 133 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05382208
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)133 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05382208
Protocol FieldVerified Registry Value
NCT IdentifierNCT05382208
Consolidated Lead SponsorWeill Medical College of Cornell University
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment133 participants (ACTUAL)
Registered Start Date2022-08-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI